Nephrology News
Targeted Therapies for Advanced RCC Improve Real-World Survival
Overall survival among patients receiving first-line targeted therapy for advanced renal cell carcinoma increased significantly from 2006 to 2012.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/